Dispersible levodopa has a fast and more reproducible onset of action than the conventional preparation in Parkinson's disease. A study with optoelectronic movement analysis

Parkinsonism and Related Disorders

Volumn 4, Issue 4, 1998, Pages 201-206

  Jansson, Yvonne ^a   Eriksson, Barbro ^a   Johnels, Bo ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Clinical response; Levodopa; Movement analysis; Parkinson's disease; Water dispersible

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; LEVODOPA;

ADULT; AGED; ARTICLE; BODY MOVEMENT; BODY POSTURE; CAMERA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ANALYSIS; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; ELECTRONICS; FEMALE; HUMAN; LOCOMOTION; MALE; MANUAL LABOR; MOTOR PERFORMANCE; ON OFF PHENOMENON; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; REPRODUCIBILITY; SCORING SYSTEM;

EID: 0032447182     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(98)00036-4     Document Type: Article

References (6)

1. Fornadi F., Milani F., Werner M. Madopar dispersible in the treatment of advanced Parkinson's disease. Clin Neuropharmacol. 17(Suppl):1994;S7-S15.
2. Johnels B., Ingvarsson P.E., Thorselius M., Valls-Matousek M., Steg G. Disability profiles and objective quantitative assessment in Parkinson's disease. Acta Neurol Scand. 79:1989;227-238.
3. Johnels B., Ingvarsson P.E., Holmberg B., Matousek M., Steg G. Single dose L-dopa response in early Parkinson's disease: Measurements with optoelectronic recording technique. Mov Disord. 8:1993;56-62.
4. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology. 17:1967;427-442.
5. Josefsson T., Nordh E., Eriksson P.O. A flexible high-precision video system for digital recording of motor acts through lightweight reflex markers. Comput Methods Programs Biomed. 49:(2):1996;119-129.
6. Fahn S, Elton RL. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Calne DB, Fahn S, Marsden CD, Goldstein M, editors. Recent developments in Parkinson's disease. Vol. 2. Florham Park, NJ: Macmillan, 1987:153-163.